Lexington Biosciences Founder: We Have a Cardiovascular Disease Prediction Device

Lexington Biosciences, Inc.’s (CSE:LNB) Donald McInnes discusses the Company’s regulatory and commercialization efforts

In an interview with SmallCapPower, Lexington Biosciences, Inc. (CSE:LNB) Founder and Board Advisor Donald McInnes explains that Lexington’s technology helps predict cardiovascular disease, which is known as the “silent killer.” Find out more about Lexington Biosciences’ regulatory and commercialization efforts by watching our interview with Donald McInnes.

To read our full disclosure, please click on the button below: